Anti-Obesity Prescription Drugs Market Report 2018 – Global Industry Analysis 2016-2024 on the Basis of Drug Class, Distribution Channel and Age Group – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Anti-Obesity
Prescription Drugs Market: Global Industry Analysis, Trends, Market Size
and Forecasts up to 2024”
report has been added to ResearchAndMarkets.com’s
offering.

The report predicts the global anti-obesity prescription drugs market to
grow with a CAGR of 4.97% over the forecast period of 2018-2024.

According to the study, the global anti-obesity prescription drugs
market is promoted by factor such as rising cases of obesity worldwide,
substantial rise in incidences of chronic diseases due to obesity and
increased work load and stress. On the other hand a stringent regulation
by the FDA is one of the restraining factors negatively affecting the
growth in the market over the forecast period.

The report on anti-obesity prescription drugs market is a comprehensive
study and presentation of drivers, restraints, opportunities, demand
factors, market size, forecasts, and trends in the global anti-obesity
prescription drugs market over the period of 2016 to 2024. Moreover, the
report is collective presentation of primary and secondary research
findings.

Porter’s five forces model in the report provides insights into the
competitive rivalry, supplier and buyer positions in the market and
opportunities for the new entrants in the global anti-obesity
prescription drugs market over the period of 2016 to 2024. Further, the
author’s Growth Matrix given in the report brings an insight on the
investment areas that existing or new market players can consider.

Segment Covered

The global anti-obesity prescription drugs market is segmented on the
basis of drug class, distribution channel and age group.

Global Anti-obesity Prescription Drugs Market by Drug Class

  • Orlistat
  • Phentermine And Topiramate
  • Bupropion And Naltrexone
  • Lorcaserin
  • Liraglutide

Global Anti-obesity Prescription Drugs Market by Distribution
Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Global Anti-obesity Prescription Drugs Market by Age Group

  • Pediatric
  • Adult

Company Profiles

  • F Hoffmann La Roche Ltd
  • Orexigen Therapeutics, Inc
  • Novo Nordisk A/S
  • Arena Pharmaceuticals, Inc
  • GlaxoSmithKline
  • VIVUS, Inc
  • Boehringer Ingelheim
  • Alizyme

For more information about this report visit https://www.researchandmarkets.com/research/vnxt43/antiobesity?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Anti-Obesity
Drugs